Get started
Keyword

FOLFOX

Description: A chemotherapy regimen combining folinic acid, fluorouracil, and oxaliplatin, used primarily to treat colorectal cancer.
Wikidata ID: wiki/Q117636
OpenAlex ID: keywords/folfox
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
2000 · Leonard B. Saltz, John V. Cox, et al. · New England Journal of Medicine · 3,005
PDF
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
2003 · Richard M. Goldberg, Daniel J. Sargent, et al. · Journal of Clinical Oncology · 2,250
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
2018 · Axel Grothey, Alberto F. Sobrero, et al. · New England Journal of Medicine · 1,086
PDF
Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07
2007 · J. Philip Kuebler, H. Samuel Wieand, et al. · Journal of Clinical Oncology · 1,056
PDF
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
2017 · Stupp, Roger, Taillibert, Sophie, et al. · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · 630
PDF
Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841
2011 · Jan Franko, Qian Shi, et al. · Journal of Clinical Oncology · 587
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
2019 · MinKe He, QiJiong Li, et al. · JAMA Oncology · 548
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
2012 · Kjell Magne Tveit, Tormod Guren, et al. · Journal of Clinical Oncology · 533
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
2009 · E. Van Cutsem, F. Rivera, et al. · Annals of Oncology · 532
XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer
2004 · Jim Cassidy, Josep Tabernero, et al. · Journal of Clinical Oncology · 525
PDF
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer
2014 · Bengt Gustavsson, Göran Carlsson, et al. · Clinical Colorectal Cancer · 519
PDF
Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
2012 · Daniel J. Sargent · JAMA · 501
Preoperative Treatment of Locally Advanced Rectal Cancer
2023 · Deborah Schrag, Qian Shi, et al. · New England Journal of Medicine · 495
PDF
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
2012 · FOxTROT Collaborative Group · The Lancet Oncology · 473
PDF
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
2014 · Thierry Conroy, Marie-Pierre Galais, et al. · The Lancet Oncology · 451
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
2021 · Qi-Jiong Li, Min-Ke He, et al. · Journal of Clinical Oncology · 435
Microsatellite Instability Testing and Its Role in the Management of Colorectal Cancer
2015 · Hisato Kawakami, Aziz Zaanan, et al. · Current Treatment Options in Oncology · 418
Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial
2014 · Deborah Schrag, Martin R. Weiser, et al. · Journal of Clinical Oncology · 415
PDF
Systemic therapies for intrahepatic cholangiocarcinoma
2020 · Robin Kate Kelley, John Bridgewater, et al. · Journal of Hepatology · 412
PDF
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
2017 · Harpreet S Wasan, Peter Gibbs, et al. · The Lancet Oncology · 403
PDF
Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial
1994 · Francis A. Lévi, Rachid Zidani, et al. · JNCI Journal of the National Cancer Institute · 396
Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study
2009 · Benoist Chibaudel, Frédérique Maindrault-Goebel, et al. · Journal of Clinical Oncology · 395
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
2015 · J. Joshua Smith, Oliver S. Chow, et al. · BMC Cancer · 391
PDF
Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms
2015 · M Heetfeld, C N Chougnet, et al. · Endocrine Related Cancer · 388
PDF
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
2014 · Yong Sang Hong, Byung-Ho Nam, et al. · The Lancet Oncology · 383
Works count: 6,267
Citation count: 78,300
Year
Topic
Type